Samsung Bioepis Outlines European Eculizumab Roll-Out

Epysqli Rival To Soliris Is First Biosimilar Solely Commercialized By Firm In Europe

 
• By David Wallace
  
Europe at night seen from space
Samsung Bioepis has started selling Epysqli in European markets • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products